. Flowchart of selection procedure GECKO. N = 1565. Cord blood stored directly after birth (-80˚C). N = 1404. Good DNA isolation (DNA concentration ≥ 50μg/ml). N = 1118. After excluding premature newborns (≤37 weeks), twins, those with a mother with (gestational) diabetes and non Dutch newborns. And those with missing information on these variables. N = 447. Newborns with information about maternal and paternal smoking during pregnancy (129 exposed to maternal smoking versus 318 unexposed to maternal and paternal smoking). N = 258. Newborns selected for methylation analysis (129 exposed versus 129 unexposed). N = 255. Final sample for methylation analysis after quality control (129 exposed versus 126 unexposed). N = 2874. Total number of participants in the GECKO Drenthe birth cohort.
ALSPAC cohort description
Design and study population ALSPAC is a large, prospective cohort study based in the South West of England. 14,541 pregnant women resident in Avon, UK with expected dates of delivery 1st April 1991 to 31st December 1992 were recruited and detailed information has been collected on these women and their offspring at regular intervals 1, 2 . The study website contains details of all the data that is available through a fully searchable data dictionary 3 . Written informed consent has been obtained for all ALSPAC participants. Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees.
As part of the Accessible Resource for Integrated Epigenomic Studies (ARIES) project 4 , the Infinium 450K BeadChip has been used to generate epigenetic data on 1,018 motheroffspring pairs in the ALSPAC cohort. The ARIES participants were selected based on availability of DNA samples at two time points for the mother (antenatal and at follow-up when the offspring were adolescents) and three time points for the offspring (neonatal, childhood (age 7) and adolescence (age 17)).
Of the 1,018 mother-offspring pairs in the ARIES project, 916 offspring had cord blood methylation data which successfully passed QC. Of these, we excluded twins, individuals with a gestational age <=37 weeks, children of mothers with diabetes during pregnancy and children missing any information on sex, gestational age, maternal age at birth, maternal prepregnancy BMI, maternal education, paternal smoking or birth weight, resulting in 678 complete cases for analysis.
Maternal smoking
Information on mothers' smoking status during pregnancy was obtained in questionnaires administered at 18 and 32 weeks gestation. Information was obtained about whether the mother smoked in each trimester of pregnancy and the number of cigarettes smoked on average per day. From these data, a dichotomous variable for sustained maternal smoking during pregnancy was derived. A mother was classified as a sustained smoker if she smoked in all three trimesters, smoked in the first and third trimester but not the second, or smoked in the second and third trimesters but not the first. The reference group consisted of mothers who had reported not smoking in all three trimesters. We excluded all individuals who smoked in one trimester only (i.e. not sustained) or who had missing information of smoking for two or more trimesters. Of those with missing information on one trimester, women were classified as a sustained smoker if they said they smoked in the other two trimesters.
Epigenome-wide association analyses
Cord blood samples were collected according to standard procedures. The DNA methylation wet-lab and pre-processing analyses were performed at the University of Bristol as part of the ARIES project. Following extraction, DNA was bisulfite converted using the Zymo EZ DNA MethylationTM kit (Zymo, Irvine, CA). Following conversion, genome-wide methylation status of over 485,000 CpG sites was measured using the Infinium HM450 Beadchip according to the standard protocol. The arrays were scanned using an Illumina iScan and initial quality review was assessed using GenomeStudio (version 2011.1).
Samples from all time points in ARIES were distributed across slides using a semirandom approach (sampling criteria were in place to ensure that all time points were represented on each array) to minimise the possibility of confounding by batch effects. In addition, during the data generation process a wide range of batch variables were recorded in a purpose-built laboratory information management system (LIMS). The main batch variable was found to be the bisulphite conversion (BCD) plate number. Samples were converted in batches of 48 samples and each batch identified by a plate number.
The LIMS also reported quality control (QC) metrics from the standard control probes on the 450K BeadChip for each sample. Samples failing QC (average probe p-value >= 0.01) were repeated and if unsuccessful excluded from further analysis. As an additional QC step genotype probes were compared with SNP-chip data from the same individual to identify and remove any sample mismatches. For individuals with no genome-wide SNP data, samples were flagged if there was a sex-mismatch based on X-chromosome methylation.
In addition to these QC steps, probes that contained <95% of signals detectable above background signal (detection p-value <0.01) (N=7,938) were excluded from analysis. After excluding these probes, as well as control probes and probes on sex chromosomes, a total of 466,432 CpGs were included in the main analysis for cord blood methylation.
This resulted in 466,432 CpGs and 678 samples were analysed using Limma for EWAS and STATA for mediation analysis.
Methylation data were pre-processed in R (version 3.0.1), with background correction and subset quantile normalisation performed using the pipeline described by Touleimat and Tost 5 .
Covariates
Variables considered as potential confounders in this analysis were offspring sex, gestational age, maternal age at birth, pre-pregnancy BMI, maternal education and paternal smoking. Gestational age and sex were recorded in the delivery room or abstracted from obstetric records and/or birth notifications. Gestational age was based on the date of the mother's last menstrual period, clinical records or ultrasounds. Maternal age at delivery was derived from date of birth, which was recorded at that time. At enrolment, the mother was asked to record her height and pre-pregnancy weight, from which BMI was calculated. Based on questionnaire responses, highest educational qualification for the mother was collapsed into a binary variable of low/middle education or university education. Information on partners' smoking during pregnancy was obtained from self-reports at 18 weeks gestation. Where selfreported data on partner smoking were not available, maternal reports were used. The bisulphite conversion batch for each sample was also included in the analysis in order to adjust for batch effects. Birth weight was considered as an outcome in this analysis. Infant birth weight was recorded in the delivery room or abstracted from obstetric records and/or birth notifications.
Generation R cohort description
Design and study population The Generation R Study is a population-based prospective cohort study from foetal life onwards in Rotterdam, the Netherlands. The study design has been described in detail elsewhere 1, 2 . All children were born between April 2002 and January 2006 and form a largely prenatally enrolled birth cohort that is being followed until young adulthood. A total of 9778 mothers were included, most during pregnancy. Response rate at birth was 61%. Epigenomewide association studies were done in 979 Caucasian children. The study protocol was approved by the Medical Ethical Committee of the Erasmus Medical Centre, Rotterdam. 
Maternal smoking
Maternal prenatal smoking was assessed by questionnaire in early (<18 weeks gestational age), mid-(18-25 weeks gestational age) and late (>25 weeks gestational age) pregnancy. Women were asked whether and how much they had smoked. Sustained smoking was defined as continued smoking of >=1 cigarette per day throughout pregnancy. Women who quit smoking during pregnancy were not classified as sustained smokers and were not included in the sustained smoking analysis.
Epigenome-wide association analyses
DNA (500 ng per sample) was extracted from cord blood and underwent bisulfite conversion (EZ-96 DNA Methylation kit (Shallow), Zymo Research Corporation, Irvine, USA). Samples were plated onto 96-well plates in no specific order and Illumina Infinium HumanMethylation450 BeadChip (Illumina Inc., San Diego, USA) arrays were run.
Quality control was performed using the following criteria: Samples were excluded in case of low sample call rate (<99%), colour balance >3, low staining efficiency, poor extension efficiency, poor hybridization performance, low stripping efficiency after extension and poor bisulfite conversion. Based on this, we excluded of 7 samples (6 for low sample call rates, 1 for poor bisulfite conversion). In addition, 2 samples were excluded because of a sex mismatch and 1 sample because of a retracted informed consent, leaving 969 samples in the analysis.
Probes with a single nucleotide polymorphism in the single base extension site with a frequency of > 1% in the GoNLv4 reference panel were excluded, as were probes with nonoptimal binding (non-mapping or mapping multiple times to either the normal or the bisulphite-converted genome), resulting in the exclusion of 49,564 probes, leaving a total of 436,013 probes in the analysis.
Data were normalized with DASES normalization using a pipeline adapted from that developed by Touleimat and Tost 3 . DASES consists of background adjustment, betweenarray normalization applied to type I and type II probes separately, and dye bias correction applied to type I and type II probes separately. DASES is based on the DASEN method described by Pidsley et al, but adds the dye bias correction 4 . We calculated beta-values all CpG sites.
Cell type correction was applied using the reference-based Houseman method 5 in the minfi package 6 in R.
Covariates
Information on maternal age, parity, maternal education and paternal smoking was collected from questionnaires which were filled in by the mother at enrolment. Maternal body mass index (BMI, kg/m 2 ) was calculated from maternal height and weight, measured without shoes and heavy clothing at enrolment in early pregnancy. Information on child sex and gestational age was obtained from midwives' and obstetrician records. Maternal age, maternal BMI and gestational age were used as continuous covariates. Parity was categorized into 0 or >=1. Maternal education was categorized into lower (none, primary or secondary education) and higher (more than secondary education). Paternal smoking was categorized into smoking and non-smoking. Analyses were additionally adjusted for batch effects by adding plate number (11 categories) as a covariate. 2 ) The coefficients βc and βc' can be interpreted as the amount of grams lower birth weight for smoking versus non-smoking mothers in the "smoking to birth weight" and full model, respectively. βb represents the effect of methylation level (coded as a proportion between 0-1) on birth weight. For cg09935388 this means that an increase of 100% in methylation level is associated with a 1190.4g higher birth weight. For extra information on the betas, see Figure 1 . 
